These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004). Shneider BL, Suchy FJ, Emre S. Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460 [Abstract] [Full Text] [Related]
8. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Barshes NR, Lee TC, Udell IW, O'mahoney CA, Karpen SJ, Carter BA, Goss JA. Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644 [Abstract] [Full Text] [Related]
10. Galactose half-life is a useful tool in assessing prognosis of chronic liver disease in children. Lampela H, Kosola S, Jalanko H, Pakarinen MP. Transpl Int; 2012 Oct; 25(10):1041-9. PubMed ID: 22816448 [Abstract] [Full Text] [Related]
11. [Predictive value of pediatrics end-stage liver disease or model for end-stage liver disease score in the prognosis of pediatric acute liver failure treated with artificial liver support system]. Jinhao T, Weiming C, Jing H, Jun H, Jian M, Peng S, Zhujin L, Guoping L, Yimin Z. Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):280-4. PubMed ID: 26182503 [Abstract] [Full Text] [Related]
12. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Cholongitas E, Theocharidou E, Vasianopoulou P, Betrosian A, Shaw S, Patch D, O'Beirne J, Agarwal B, Burroughs AK. Liver Transpl; 2012 Apr; 18(4):405-12. PubMed ID: 22213443 [Abstract] [Full Text] [Related]
19. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333 [Abstract] [Full Text] [Related]
20. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N. Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024 [Abstract] [Full Text] [Related] Page: [Next] [New Search]